Centerra Gold
CGAU
21.15
-0.54
-2.49%
Centerra Gold
US · CGAU
#2257 by market cap
Listed 1970
21.15
-0.54
-2.49%
Live - 5344 symbols - heartbeat 225s ago
· 2026-10-08 07:58
Pre-market
21.24
+0.43%
After-hours
21.15
0.00%
- Market cap
- 4.14B
- P/E (TTM)i
- 6.74
- P/Bi
- 1.91
- EPSi
- 2.84
- Div yieldi
- 0.96%
- 52W posi
- 76%
Reader sentiment
Are you bullish or bearish on CGAU?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.47, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +14.00% YoY
Margins
- Gross margin
- 33.50%
- Operating margin
- 22.71%
- Net margin
- 42.18%
Key ratios & quality
- Altman Z-Scorei
- 4.47
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.13B | 1.38B | 721.26M | 900.14M | 850.19M | 1.09B | 1.21B | 1.38B |
| Gross profit | 343.35M | 450.09M | 215.49M | 291.96M | 178.52M | 264.01M | 378.05M | 463.79M |
| Selling & admin expenses | 36.92M | 55.88M | 55.76M | 38.47M | 60.14M | 57.09M | 48.57M | 71.56M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 99.68M | 140.42M | 41.66M | 172.29M | 103.49M | 42.98M | 236.29M | 314.43M |
| Pretax profit | 98.82M | -100.58M | 23.85M | 402.93M | -44.43M | 13.63M | 174.06M | 731.01M |
| Tax | -14.65M | -7.07M | 7.71M | -44.02M | 32.78M | 94.91M | 93.66M | 147.02M |
| Net profit | 107.53M | -93.51M | 408.54M | -381.77M | -77.21M | -81.28M | 80.39M | 583.99M |
| Basic EPS | 0 | 0 | 1 | -1 | 0 | 0 | 0 | 3 |
| Diluted EPS | 0.36 | -0.32 | 1.37 | -1.29 | -0.31 | -0.38 | 0.35 | 2.84 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 299.50M | 288.34M | 395.16M | 401.56M | 484.69M | 442.71M |
| Gross profit | 76.54M | 87.44M | 136.43M | 163.39M | 197.61M | 159.01M |
| Selling & admin expenses | 13.11M | 12.41M | 18.25M | 27.80M | 27.28M | 13.40M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 44.30M | 68.59M | 91.98M | 109.57M | 147.28M | 118.41M |
| Pretax profit | 55.28M | 66.42M | 351.77M | 257.54M | 132.63M | 126.30M |
| Tax | 24.82M | -2.16M | 59.58M | 64.77M | 53.20M | 54.18M |
| Net profit | 30.45M | 68.57M | 292.19M | 192.77M | 79.43M | 72.12M |
| Basic EPS | 0 | 0 | 1 | 1 | 0 | 0 |
| Diluted EPS | 0.13 | 0.32 | 1.43 | 0.95 | 0.39 | 0.35 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 814.52M | 932.67M | 1.37B | 1.27B | 990.66M | 966.03M | 993.06M | 1.07B |
| Cash & ST investments | 151.71M | 44.50M | 548.67M | 949.40M | 532.75M | 615.78M | 627.80M | 540.90M |
| Inventory | 577.44M | 774.06M | 580.59M | 221.22M | 316.80M | 257.30M | 234.25M | 333.72M |
| Total assets | 2.83B | 2.70B | 3.14B | 2.68B | 2.34B | 2.28B | 2.27B | 2.96B |
| Total current liabilities | 234.78M | 244.81M | 257.83M | 227.35M | 274.85M | 297.44M | 283.88M | 446.90M |
| Short-term debt | 5.80M | 4.30M | 4.58M | 6.14M | 5.25M | 6.11M | 6.39M | 7.92M |
| Long-term debt | 179.27M | 70.01M | -- | -- | -- | -- | -- | -- |
| Total liabilities | 678,680,000.00 | 635,809,000.00 | 669,991,000.00 | 632,952,000.00 | 525,618,000.00 | 606,524,000.00 | 609,217,000.00 | 898,888,000.00 |
| Total equity | 2.15B | 2.07B | 2.47B | 2.04B | 1.81B | 1.67B | 1.66B | 2.06B |
| Retained earnings | 1.17B | 1.08B | 1.45B | 1.02B | 897.57M | 771.39M | 808.27M | 1.35B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.01B | 967.21M | 1.07B | 1.07B | 1.13B | 1.11B |
| Cash & ST investments | 611.90M | 522.34M | 568.23M | 540.90M | 554.51M | 457.20M |
| Inventory | 223.57M | 241.68M | 293.82M | 333.72M | 381.30M | 423.58M |
| Total assets | 2.31B | 2.32B | 2.69B | 2.96B | 3.08B | 3.10B |
| Total current liabilities | 314.67M | 279.69M | 370.81M | 446.90M | 470.79M | 457.01M |
| Short-term debt | 6.31M | 6.44M | 6.16M | 7.92M | 8.20M | 8.88M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 649,038,000.00 | 613,588,000.00 | 750,525,000.00 | 898,888,000.00 | 978,040,000.00 | 927,741,000.00 |
| Total equity | 1.66B | 1.70B | 1.94B | 2.06B | 2.10B | 2.17B |
| Retained earnings | 828.46M | 886.45M | 1.17B | 1.35B | 1.42B | 1.48B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 217.49M | 334.15M | 930.02M | 414.76M | -1.98M | 245.60M | 298.40M | 348.63M |
| Depreciation & amortization | 200.80M | 245.75M | 102.05M | 126.37M | 103.43M | 129.69M | 130.66M | 115.64M |
| Free cash flow | -68.38M | 34.71M | 826.45M | 322.26M | -82.91M | 160.29M | 114.11M | 51.92M |
| Dividends paid | 0 | 0 | -39.76M | -45.04M | -47.67M | -44.91M | -43.51M | -41.12M |
| Stock buybacks / issuance | 1.00M | 7.95M | 7.79M | 5.04M | -101.02M | -18.36M | -40.17M | -88.28M |
| Ending cash balance | 151.71M | 42.72M | 545.18M | 947.23M | 531.92M | 612.94M | 624.67M | 528.93M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 58.61M | 25.31M | 161.65M | 103.06M | 120.09M | 66.18M |
| Depreciation & amortization | 24.87M | 26.88M | 36.10M | 27.80M | 34.10M | 34.71M |
| Free cash flow | 10.04M | -25.58M | 98.64M | -31.19M | 49.01M | -22.96M |
| Dividends paid | -10.27M | -10.58M | -10.28M | -9.99M | -10.12M | -9.98M |
| Stock buybacks / issuance | -14.06M | -25.65M | -21.37M | -27.21M | -21.03M | -49.24M |
| Ending cash balance | 608.17M | 522.34M | 561.80M | 528.93M | 543.49M | 450.85M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.15 | -4.44 | 18.03 | -16.93 | -4.01 | -4.67 | 4.83 | 31.43 |
| ROA %i | 3.84 | -3.38 | 14.00 | -13.14 | -3.08 | -3.52 | 3.54 | 22.36 |
| ROIC %i | 5.12 | -3.87 | 17.79 | -16.76 | -4.30 | -5.26 | 3.31 | 30.28 |
| 5-year avg ROE %i | 5.05 | 4.78 | 7.79 | 2.54 | -0.44 | -2.40 | -0.55 | 2.13 |
| EBIT margin %i | 10.15 | -6.81 | 24.92 | 44.85 | -5.15 | 1.31 | 14.42 | 52.90 |
| FCF / sales %i | -- | 2.52 | 35.75 | 35.80 | -- | 14.64 | 9.40 | 3.75 |
| Current ratioi | 3.47 | 3.81 | 5.32 | 5.59 | 3.60 | 3.25 | 3.50 | 2.39 |
| Quick ratioi | 0.90 | 0.55 | 2.38 | 4.51 | 2.36 | 2.31 | 2.63 | 1.60 |
| Debt / assetsi | 6.70 | 3.43 | 0.60 | 0.75 | 0.60 | 1.06 | 0.89 | 0.64 |
| LT debt / equityi | 8.54 | 4.28 | 0.58 | 0.69 | 0.48 | 1.08 | 0.83 | 0.53 |
| Interest coveragei | 7.27 | -13.50 | 92.81 | 524.29 | -64.44 | 21.75 | 160.69 | 506.54 |
| Revenue CAGR (3Y) %i | 21.87 | 21.98 | -15.58 | -7.28 | -14.81 | 14.93 | 10.50 | 17.65 |
| Net income CAGR (3Y) %i | 37.21 | -- | 24.93 | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -39.74 | 54.19 | -- | -- | -42.12 | -29.25 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 2.63 | 4.38 | 18.39 | 31.43 | 33.69 | 32.89 |
| ROA %i | 1.92 | 3.27 | 13.48 | 22.36 | 23.51 | 23.52 |
| ROIC %i | 1.32 | 3.19 | 17.29 | 30.28 | 32.42 | 31.80 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.14 | 12.02 | 34.25 | 52.90 | 51.64 | 50.55 |
| FCF / sales %i | 5.58 | 5.68 | 10.12 | 3.75 | 5.79 | 5.42 |
| Current ratioi | 3.20 | 3.46 | 2.89 | 2.39 | 2.41 | 2.42 |
| Quick ratioi | 2.45 | 2.52 | 2.05 | 1.60 | 1.56 | 1.46 |
| Debt / assetsi | 0.84 | 0.84 | 0.66 | 0.64 | 1.42 | 1.48 |
| LT debt / equityi | 0.79 | 0.77 | 0.59 | 0.53 | 1.69 | 1.70 |
| Interest coveragei | 84.20 | 77.08 | 403.52 | 506.54 | 355.39 | 260.02 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Mount Milligan is the largest reported line at 41.12% of revenue, across 3 reported segments.
- No single line clears half of revenue; Öksüt is next at 31.91%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Mount Milligan41.12%
Öksüt31.91%
US Moly26.96%
Quote time 2026-10-08 07:58:33 · For reference only, not investment advice and not tailored to your situation.